Moderna says it will increase its global supply of Covid-19 vaccines to up to 3bn next year as the company expands its manufacturing capacity to tackle new and existing strains of the virus.
The investment to boost production comes as India grapples with a severe wave of coronavirus fuelled by a new variant of the virus that has pushed its health system to the brink of collapse.
Stéphane Bancel, chief executive of Moderna, told the Financial Times that he was awaiting data about the B.1.617 strain circulating in India but that it was highly concerning.
您已閱讀13%（556字），剩餘87%（3601字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。